Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 27, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Homology Medicines, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 25
| |||||||
Homology Medicines, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Kala Bio, Inc.
| 9.76K |
$6.73 | -$30,547.47 | +3.53% | 286.31K |
Jan 4
| |||||||
Akero Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 23
| |||||||
Kala Pharmaceuticals, Inc.
| 158.87K |
—
|
—
| +135.00% | 276.55K |
Jun 22
| |||||||
Merus N.V.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Aerovate Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Third Harmonic Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Kala Pharmaceuticals, Inc.
| 71.72K |
—
|
—
| +156.02% | 117.68K |
May 31
| |||||||
Merus N.V.
| 73.58K |
$7.27 | $534,679.12 |
∞
| 73.58K |
Apr 14
| |||||||
Kala Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 14
| |||||||
Third Harmonic Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 6
| |||||||
Kala Pharmaceuticals, Inc.
| 41.5K |
$28.54 | -$5,650.92 | +929.70% | 45.97K |
Jan 4
|
Scheduled
| ||||||
Kala Pharmaceuticals, Inc.
| -561.00 |
$6.52 | -$3,657.72 | -11.16% | 4.46K |
Oct 26
|
Scheduled
| ||||||
Third Harmonic Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 26
| |||||||
Third Harmonic Bio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Kala Pharmaceuticals, Inc.
| -7.97K |
$0.37 | -$2,950.75 | -3.08% | 251.18K |
Jun 27
|
Scheduled
| ||||||
Aerovate Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 21
| |||||||
Akero Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 2
| |||||||
Merus N.V.
|
0
|
—
|
—
|
—
|
0
|
May 31
| |||||||
Kala Pharmaceuticals, Inc.
| -9.52K |
$1.30 | -$12,373.40 | -3.54% | 259.16K |
Jan 3 - Jan 4
|
Scheduled
| ||||||
Kala Pharmaceuticals, Inc.
| -27.60K |
$1.80 | -$49,676.40 | -9.32% | 268.68K |
Oct 26
|
Scheduled
| ||||||
Aerovate Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 2 - Jun 29
| |||||||
Aerovate Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Kala Pharmaceuticals, Inc.
| -7.59K |
$5.77 | -$43,771.22 | -2.50% | 296.27K |
Jun 28
|
Scheduled
| ||||||
Akero Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Merus N.V.
|
0
|
—
|
—
|
—
|
0
|
May 28
| |||||||
Pulmatrix, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 28
| |||||||
Kala Pharmaceuticals, Inc.
| 76K |
—
|
—
| +33.35% | 303.86K |
Jan 4
| |||||||
Kala Pharmaceuticals, Inc.
| 178.3K |
—
|
—
| +359.77% | 227.86K |
Oct 26
| |||||||
Aimmune Therapeutics, Inc.
| -47.41K |
$34.50 | -$1,635,541.50 | -100.00% |
0
|
Oct 10 - Oct 13
| |||||||
Merus N.V.
|
0
|
—
|
—
|
—
|
0
|
Jun 30
| |||||||
Kala Pharmaceuticals, Inc.
| 49.56K |
—
|
—
|
∞
| 49.56K |
Jun 25
| |||||||
Akero Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Aimmune Therapeutics, Inc.
| 7.84K |
—
|
—
| +19.81% | 47.41K |
May 27
| |||||||
Pulmatrix, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 2
| |||||||
Pulmatrix, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 9
| |||||||
Kala Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 2
| |||||||
Merus N.V.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Akero Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.